Suppr超能文献

非典型畸胎样/横纹肌样瘤中染色质状态的综合分析确定了 SWI/SNF 和 Polycomb 在基因调控中的不同作用。

Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.

机构信息

Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; European Molecular Biology Laboratory, Genome Biology Unit, 69117 Heidelberg, Germany; Izmir Biomedicine and Genome Center, 35340 Izmir, Turkey.

Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120 Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Pediatric Hematology and Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

出版信息

Cancer Cell. 2019 Jan 14;35(1):95-110.e8. doi: 10.1016/j.ccell.2018.11.014. Epub 2018 Dec 27.

Abstract

Biallelic inactivation of SMARCB1, encoding a member of the SWI/SNF chromatin remodeling complex, is the hallmark genetic aberration of atypical teratoid rhabdoid tumors (ATRT). Here, we report how loss of SMARCB1 affects the epigenome in these tumors. Using chromatin immunoprecipitation sequencing (ChIP-seq) on primary tumors for a series of active and repressive histone marks, we identified the chromatin states differentially represented in ATRTs compared with other brain tumors and non-neoplastic brain. Re-expression of SMARCB1 in ATRT cell lines enabled confirmation of our genome-wide findings for the chromatin states. Additional generation of ChIP-seq data for SWI/SNF and Polycomb group proteins and the transcriptional repressor protein REST determined differential dependencies of SWI/SNF and Polycomb complexes in regulation of diverse gene sets in ATRTs.

摘要

SMARCB1 基因的双等位基因失活,编码了 SWI/SNF 染色质重塑复合物的一个成员,是典型的胚胎发育不良性横纹肌瘤(ATRT)的标志性遗传异常。在这里,我们报告了 SMARCB1 的缺失如何影响这些肿瘤中的表观基因组。我们使用原发性肿瘤的染色质免疫沉淀测序(ChIP-seq),对一系列活性和抑制性组蛋白标记物进行了研究,确定了与其他脑肿瘤和非肿瘤性脑相比,在 ATRT 中差异表达的染色质状态。在 ATRT 细胞系中重新表达 SMARCB1,使我们能够对全基因组范围内的染色质状态发现进行验证。进一步生成 SWI/SNF 和 Polycomb 组蛋白以及转录抑制蛋白 REST 的 ChIP-seq 数据,确定了 SWI/SNF 和 Polycomb 复合物在调节 ATRT 中不同基因集方面的差异依赖性。

相似文献

4
NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.
Mol Cell. 2022 Jul 7;82(13):2472-2489.e8. doi: 10.1016/j.molcel.2022.04.015. Epub 2022 May 9.
5
Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
J Neurooncol. 2019 Jan;141(1):43-55. doi: 10.1007/s11060-018-03018-6. Epub 2018 Nov 16.
6
SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus.
Mol Cell Biol. 2008 May;28(10):3457-64. doi: 10.1128/MCB.02019-07. Epub 2008 Mar 10.
9
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression.
Nat Commun. 2024 Aug 24;15(1):7303. doi: 10.1038/s41467-024-51566-5.
10
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Acta Neuropathol. 2021 Feb;141(2):291-301. doi: 10.1007/s00401-020-02250-7. Epub 2020 Dec 17.

引用本文的文献

2
Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation.
Front Oncol. 2025 Jun 17;15:1569548. doi: 10.3389/fonc.2025.1569548. eCollection 2025.
3
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.
Int J Mol Sci. 2025 Feb 25;26(5):1973. doi: 10.3390/ijms26051973.
4
SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1.
Cancer Gene Ther. 2025 Mar;32(3):327-342. doi: 10.1038/s41417-025-00873-0. Epub 2025 Feb 19.
5
SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRT.
Mol Cancer Res. 2025 Jun 3;23(6):515-529. doi: 10.1158/1541-7786.MCR-24-0926.
6
Development and epigenetic regulation of Atypical teratoid/rhabdoid tumors in the context of cell-of-origin and halted cell differentiation.
Neurooncol Adv. 2024 Sep 23;6(1):vdae162. doi: 10.1093/noajnl/vdae162. eCollection 2024 Jan-Dec.
9
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors.
Life Sci Alliance. 2024 Mar 18;7(6). doi: 10.26508/lsa.202302088. Print 2024 Jun.
10
SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
Nat Commun. 2023 Dec 1;14(1):7762. doi: 10.1038/s41467-023-43498-3.

本文引用的文献

4
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Cancer Cell. 2016 Dec 12;30(6):891-908. doi: 10.1016/j.ccell.2016.11.003.
5
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
Nat Genet. 2017 Feb;49(2):289-295. doi: 10.1038/ng.3746. Epub 2016 Dec 12.
6
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery.
Cell. 2016 Nov 17;167(5):1145-1149. doi: 10.1016/j.cell.2016.11.007.
7
Atypical teratoid/rhabdoid tumors: challenges and search for solutions.
Cancer Manag Res. 2016 Sep 16;8:115-125. doi: 10.2147/CMAR.S83472. eCollection 2016.
10
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.
Cancer Cell. 2016 Apr 11;29(4):464-476. doi: 10.1016/j.ccell.2016.03.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验